Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India
- PMID: 32299795
- DOI: 10.1136/annrheumdis-2020-217509
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India
Keywords: antirheumatic agents; autoimmune diseases; biological therapy; communicable diseases, imported; glucocorticoids.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa et al.Ann Rheum Dis. 2021 Apr;80(4):e47. doi: 10.1136/annrheumdis-2020-217953. Epub 2020 Jun 11. Ann Rheum Dis. 2021. PMID: 32527864 No abstract available.
-
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort.Ann Rheum Dis. 2021 Apr;80(4):e46. doi: 10.1136/annrheumdis-2020-217806. Epub 2020 Jun 11. Ann Rheum Dis. 2021. PMID: 32527866 No abstract available.
Comment on
-
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
